Mirum Pharmaceuticals (MIRM) Other Non-Current Assets (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Other Non-Current Assets of $16.2 million for Q1 2026, up 195.6% year-over-year from $5.5 million in Q1 2025, and up 34.64% quarter-over-quarter from $12.0 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $16.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 195.6% year-over-year to $16.2 million; the TTM figure through Mar 2026 stood at $16.2 million (up 195.6% YoY), while the FY2025 annual figure was $12.0 million, up 123.3% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $16.2 million, up from $12.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $16.2 million in Q1 2026, with the low at $1.2 million in Q2 2023.
- The 5-year median for Other Non-Current Assets is $4.0 million (2024), against an average of $4.9 million.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets plunged 34.24% in 2023, then surged 256.29% in 2024.
- Mirum Pharmaceuticals' Other Non-Current Assets stood at $1.4 million in 2022, then jumped by 201.37% to $4.2 million in 2023, then increased by 29.22% to $5.4 million in 2024, then surged by 123.3% to $12.0 million in 2025, then jumped by 34.64% to $16.2 million in 2026.
- Business Quant data shows MIRM's Other Non-Current Assets at $16.2 million in Q1 2026, $12.0 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 22.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.24 Mn |
| Mar 31, 2026 | 16.18 Mn |
| Dec 31, 2025 | 12.02 Mn |
| Sep 30, 2025 | 9.92 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 5.38 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 3.87 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.64 Mn |